# A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)

> clinical trial · VERIFIED · 2026-08-18

Status: ACTIVE_NOT_RECRUITING · Sponsor: AstraZeneca · Condition: Neurofibromatosis 1

- Company: AstraZeneca
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04590235

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.